News

Media contact: Lissa Quirino, pr@3tbiosciences.com

3T Biosciences to Present at BIO CEO & Investor Digital Conference

February 16, 2021

3T Biosciences to Present at Biotech Showcase Digital 2021

January 8, 2021

3T Biosciences Appoints Industry Veteran John Connolly as Interim CEO

December 16, 2020

High Throughput Technology Drives Developments in Personalized Cancer Immuno-therapies

June 9, 2020

Forbes: 3T Biosciences

May 5, 2020

Peter Thiel Among Investors Who Helped 3T Biosciences Close a $12 Million Funding Round

October 7, 2017